Disitamab vedotin Antibody
Disitamab vedotin (RC-48) is a HER2-targeting antibody-drug conjugate (ADC) that delivers the cytotoxic agent MMAE. It demonstrates potent anti-tumor activity in vitro and in vivo against gastric cancer models with varying HER2 expression, inhibiting proliferation and downregulating HER2 protein levels.
Product Specifications
Product Name Alternative
EGFR, Disitamab vedotin, ADCs, AntibodyDrug Conjugates (ADCs), Antibody-Drug Conjugates (ADCs), Antibody-Drug Conjugates, AntibodyDrugConjugates, AntibodyDrugConjugates (ADCs), RC 48, RC48, RC-48
Target
Antibody-Drug Conjugates (ADCs), EGFR
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cardiovascular Research, Signal Transduction
Concentration
20.6 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
149 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6472014-01 0.1 mL
DCT, NT (Tyrosinase-related Protein 2, TRP-2, TRP2, L-dopachrome Delta-isomerase, L-dopachrome Tautomerase, DT, TYRP2) (MaxLight 405)
Sign In for Pricing
View Details MBS6472014-02 5x 0.1 mL
DCT, NT (Tyrosinase-related Protein 2, TRP-2, TRP2, L-dopachrome Delta-isomerase, L-dopachrome Tautomerase, DT, TYRP2) (MaxLight 405)
Sign In for Pricing
View Details 